About
GlyTR Therapeutics is a biotech company developing a novel class of immunotherapeutic molecules and CAR-T cell therapies that target multiple cancer antigens across both solid and blood cancers.
Explore GlyTR Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.